BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2015
View Archived Issues
TaiRx starts phase I trial of oral anticancer drug TRX-818
Read More
Blood cytokine biomarker signature detects tuberculosis and identifies dormant/active forms
Read More
Merck & Co. initiates phase I trial of MK-8591 for HIV-1 infection
Read More
Otonomy receives IND application clearance for tinnitus candidate OTO-311
Read More
VIS-410 shows activity and reduced duration of symptoms in phase IIa challenge study
Read More
Turing Pharmaceuticals files IND for TUR-004
Read More
Temsirolimus in recurrent bladder cancer treatment
Read More
ContraVir reports preliminary data for tenofovir prodrug in HBV
Read More
Proenkephalin plasma levels linked to CKD incidence
Read More
Ribociclib and binimetinib in combination for NRAS-mutant melanoma
Read More
Insero Health merges into Biscayne Pharmaceuticals
Read More
BARDA awards contract to Stratatech for StrataGraft skin substitute
Read More
Biosimilar ONS-1045 meets primary and secondary endpoints in phase I trial
Read More
SanBio starts phase II trial of stem cell therapy SB-623 in traumatic brain injury
Read More
RAD-1901: hybrid SERM/SERD active in breast cancer-derived brain metastasis models
Read More
Axovant Sciences begins phase III MINDSET study
Read More
Novel DYM mutations related to rare Dyggve-Melchior-Clausen syndrome
Read More
Vitamin B12 deficiency linked to diabetic cardiovascular autonomic neuropathy
Read More
Merck & Co. reports TrkA inhibitors
Read More
Janssen discloses c-Ros-1 inhibitors
Read More
Beijing Hanmi patents ROR-gamma modulators
Read More
Synta Pharmaceuticals HSP90-targeted SDC-TRAPs
Read More
Chungnam National University introduces cardiac myosin activators
Read More
Tarix Orphan receives FDA fast track designation for TXA-127 in DMD
Read More
Akebia reaches agreement with FDA and EMA on phase III program for vadadustat
Read More
Genzyme completes acquisition of vandetanib from AstraZeneca
Read More
FDA places clinical hold on axalimogene filolisbac
Read More
Guadecitabine receives FDA orphan drug designation for AML
Read More